Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Family support predicts psychiatric medication usage among Mexican American individuals with schizophrenia

  • 542 Accesses

  • 39 Citations

Abstract

Background

Support provided by family caregivers to persons with schizophrenia is a viable intervention focus to improve psychiatric medication usage. However, little is known about the relation between medication usage and family support as well as other key caregiving factors.

Method

Family support and Expressed Emotion (EE) dimensions were tested as predictors of medication usage during a 9-month period following psychiatric hospital discharge in a sample of 30 individuals of Mexican descent with schizophrenia.

Results

Family instrumental support predicted higher medication usage (Odds Ratio = 4.8) in multivariate analyses that statistically adjusted for the impact of emotional support, family EE, and psychiatric status (e.g., positive symptoms) on medication usage.

Conclusions

Findings suggest that efforts to improve medication usage among Mexican American individuals with schizophrenia should take into account social supportive factors such as instrumental or directive, hands-on assistance from family caregivers.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Ellison JM, Blum N, Barsky AJ (1986) Repeat visitors in the psychiatric emergency service: a critical review. Hosp Community Psych 37:37–41

  2. 2.

    Fenton WS, Byler C, Heinsesen R (1997) Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 23:637–651

  3. 3.

    Young JL, Zonana HV, Shelper L (1986) Medicatin noncompliance in schizophrenia: codification and update. Bull Am Acad Psychiatry Law 14:105–122

  4. 4.

    Marder SR (1998) Facilitating compliance with antipsychotic medication. J Clin Psychiatry 59:21–25

  5. 5.

    Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV (2002) Prevalence of and risk for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63:892–909

  6. 6.

    Singer JD, Willet JB (1991) Modeling the days of our lives: using survival analysis when designing and analyzing longitudinal studies of duration and the timing of events. Psychol Bull 110:268–290

  7. 7.

    Mari JJ, Streiner DL (1994) An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings. Psychol Med 24:565–578

  8. 8.

    McFarlane WR, Link B, Dushay R, Marchal J, Crilly J (1995) Psychoeducational multiple family groups: four-year relapse outcome in schizophrenia. Fam Process 34:127–144

  9. 9.

    Bebbington P, Kuipers L (1994) The predictive utility of expressed emotion in schizophrenia: an aggregate analysis. Psychol Med 24:707–718

  10. 10.

    Butzlaff RL, Hooley JM (1998) Expressed emotion and psychiatric relapse. Arch Gen Psych 55:547–552

  11. 11.

    Jenkins J, Karno M (1992) The meaning of expressed emotion: theoretical issues raised by cross-cultural research. Am J Psychiatry 149:9–21

  12. 12.

    Lefley HP (1990) Culture and chronic mental illness. Hosp Community Psychiatry 41(3):277–286

  13. 13.

    Guarnaccia PJ, Parra P (1996) Ethnicity, social status, and families experiences of caring for a mentally ill family member. Community Ment Health J 32:243–260

  14. 14.

    Ramírez García JI, Wood JM, Hosch HM, Meyer LD (2004) Predicting psychiatric rehospitalizations: examining the role of Latino versus European American ethnicity. Psychol Serv 1:147–157

  15. 15.

    López SR, Hipke KN, Polo AJ, Jenkins J, Karno M, Vaughn C, Zinder KS (2004) Ethnicity, expressed emotion, attributions, and course of schizophrenia: family warmth matters. J Abnorm Psychol

  16. 16.

    Steidel AG, Contreras JM (2003) A new familism scale for use with Latino populations. Hisp J Behav Sci 25:312–330

  17. 17.

    Hosch HM, Meyer LD, Barrientos GA, Fierro C, Ramírez JI, Moreno A, Pelaez MP, Pérez Y (1995) Predicting adherence to medication by Hispanics with schizophrenia. Hisp J Behav Sci 17:320–333

  18. 18.

    Barrera M Jr (2000) Social support research in community psychology. In: Rappaport J, Seidman E (eds) Handbook of community psychology. Kluwer Academic/Plenum Publishers, New York, NY, pp 215–246

  19. 19.

    Karno M, Jenkins JH, de la Selva A, Santana F, Telles C, López SR, Mintz J (1987) Expressed emotion and schizophrenic outcome among Mexican-American families. J Nerv Ment Dis 175:377–386

  20. 20.

    Wing JK, Cooper JE, Sartorious N (1974) The measurement and classification of psychiatric symptoms. Cambridge University Press, London

  21. 21.

    Vaughn CE, Leff J (1976) The measurement of expressed emotion in the families of psychiatric patients. Br J Psychiatry 129:125–137

  22. 22.

    Vaughn CE, Snyder KS, Jones S, et al. (1984) Family factors in schizophrenic relapse: Replication in California of British research on expressed emotion. Arch Gen Psychiatry 41:1169–1177

  23. 23.

    Kopelowicz A, López SR, Zarate R, O’Brien M, Gordon J, Chang C, Gonzalez-Smith V (2006) Expressed emotion and family interactions in Mexican Americans with schizophrenia. J Nerv Ment Dis 194:330–334

  24. 24.

    Chang CL, López SR, Murray AM, Jenkins JH, Karno M (2006) Prosocial processes in caring for relatives with schizophrenia: families’ affective reactions, social support and expressed emotion. (Manuscript submitted for publication)

  25. 25.

    Shrout P, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 83:762–765

  26. 26.

    Krawiecka M, Goldberg D, Vaughan M (1977) A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psych Scand 55:299–308

  27. 27.

    Baron RB, Kenny DA (1986) The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182

  28. 28.

    Cohen J, Cohen P, West SG, Aiken LS (2003) Applied multiple regression/correlation analyses for the behavioral sciences, (3rd edn). Lawrence Erlbaum Associates, New Jersey

  29. 29.

    Pampel FC (2000) Logistic regression: a primer. Sage, Thousand Oaks, CA

  30. 30.

    Sellwood W, Tarrier N, Quinn J, Barrowclough C (2003) The family and compliance in schizophrenia: the influence of clinical variables, relative’s knowledge, and expressed emotion. Psychol Med 33:91–96

Download references

Acknowledgements

This research was supported by a National Institute of Mental Health NRSA Training Grant MH14584 (Psychological Research on Schizophrenic Conditions) to the first author. An earlier version of this paper was presented at the Family Research Consortium IV, San Juan, Puerto Rico, in July 2004 with support from NIMH to the first author. The paper is partially based on the Honors Thesis of the third author. The first author would like to thank Nicole Allen, Howard Berenbaum, Adriana Umaña-Taylor, and Edelyn Verona for their input on previous drafts.

Author information

Correspondence to Jorge I. Ramírez García.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ramírez García, J.I., Chang, C.L., Young, J.S. et al. Family support predicts psychiatric medication usage among Mexican American individuals with schizophrenia. Soc Psychiat Epidemiol 41, 624–631 (2006). https://doi.org/10.1007/s00127-006-0069-8

Download citation

Key words

  • medication usage or medication compliance
  • schizophrenia
  • family support
  • expressed emotion
  • Mexican Americans